By comparison, DPV method showed wider linear range (0.01 100 ng mL−1) and lower limit of detection (3 pg mL−1) than those (3.3 330 ng mL−1 and 1.6 ng mL−1) of ELISA.
The proposed method showed wide linear range of 0.005 5 unit/mL and low detection limit of 0.0018 unit/mL (S/N = 3).
Using carcinoembryonic antigen and α-fetoprotein as model analytes, this method showed wide linear ranges with the detection limits down to 3.2 and 4.0 pg/mL, respectively.
Under optimal conditions, the proposed immunoassay method showed wide linear range from 0.05 pg mL−1 to 1 ng mL−1 and a detection limit down to 0.024 pg mL−1.
Under optimized conditions, this method showed wide linear ranges of three orders of magnitude with the detection limits of 4 pg mL−1 and 5 pg mL−1, respectively.
Under the optimum extraction conditions, the method shows wide linear ranges and low limits of detection and quantification between 0.03-0.15 and 0.09-0.55 μg L−1, respectively.
All methods showed a genome-wide type 1 error which was very close, but lower than the pre-specified threshold of 5% (Figure 2A).
3, 4 Recently, studies employing unbiased and genome-wide methods showed that the genetic alterations were involved in the pathophysiology of PTCL.
The results of different methods show a wide range of scatter, however some recommendations for their applicability can be given.
Consequently, results obtained by different researchers using different analytical methods show a wide variation in URLs [8, 9, 10, 13, 14].
